
TIANYU BIO-TECHNOLOGY CO.,LTD. — Investor Relations & Filings
TIANYU BIO-TECHNOLOGY CO.,LTD. specializes in the research, development, and large-scale production of active pharmaceutical ingredients (APIs) and advanced pharmaceutical intermediates. The company focuses on therapeutic areas such as cardiovascular health, diabetes management, and anti-viral treatments. Its core product portfolio includes various sartan-based intermediates and other complex organic synthesis products. TIANYU BIO-TECHNOLOGY emphasizes rigorous quality management systems and adheres to international regulatory standards to ensure product safety and efficacy. By leveraging advanced chemical synthesis technologies and a robust R&D infrastructure, the company provides customized manufacturing solutions and high-quality chemical components to global pharmaceutical partners. Its operations are characterized by a commitment to technical innovation and process optimization in the synthesis of complex molecules.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 天域生态关于向2022年股票期权激励计划激励对象授予预留部分股票期权的公告 | 2023-04-04 | Chinese | |
| 天域生态关于完成工商变更登记并取得营业执照的公告 | 2023-03-27 | Chinese | |
| 公司章程(2023年3月修订) | 2023-03-27 | Chinese | |
| 天域生态关于公司2022年度对外担保预计的进展公告 | 2023-03-27 | Chinese | |
| 关于天域生态环境股份有限公司向特定对象发行股票申请文件的审核中心意见落实函的回复 | 2023-03-24 | Chinese | |
| 关于公司向特定对象发行股票申请文件的审核中心意见落实函的回复及募集说明书等申请文件更新的提示性公告 | 2023-03-24 | Chinese |
Browse filings by year
10 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2023
15 filings
| |||||
| 38185304 | 天域生态关于向2022年股票期权激励计划激励对象授予预留部分股票期权的公告 | 2023-04-04 | Chinese | ||
| 38185290 | 天域生态关于完成工商变更登记并取得营业执照的公告 | 2023-03-27 | Chinese | ||
| 38185278 | 公司章程(2023年3月修订) | 2023-03-27 | Chinese | ||
| 38185261 | 天域生态关于公司2022年度对外担保预计的进展公告 | 2023-03-27 | Chinese | ||
| 38185248 | 关于天域生态环境股份有限公司向特定对象发行股票申请文件的审核中心意见落实函的回复 | 2023-03-24 | Chinese | ||
| 38185215 | 关于公司向特定对象发行股票申请文件的审核中心意见落实函的回复及募集说明书等申请文件更新的提示性公告 | 2023-03-24 | Chinese | ||
| 38185199 | 天域生态环境股份有限公司向特定对象发行A股股票募集说明书(申报稿) | 2023-03-24 | Chinese | ||
| 38185125 | 众华会计师事务所(特殊普通合伙)关于天域生态环境股份有限公司向特定对象发行股票申请文件的审核中心意见落实函的回复 | 2023-03-24 | Chinese | ||
| 38185112 | 天域生态关于公司2022年度对外担保预计的进展公告 | 2023-03-24 | Chinese | ||
| 38185096 | 北京德恒律师事务所关于天域生态环境股份有限公司2022年度向特定对象发行A股股票的补充法律意见书 | 2023-03-24 | Chinese | ||
| 38185080 | 独立董事关于第四届董事会第十一次会议相关议案的独立意见 | 2023-03-20 | Chinese | ||
| 38185070 | 关于收到上海证券交易所关于公司向特定对象发行股票的审核中心意见落实函的公告 | 2023-03-20 | Chinese | ||
| 38185057 | 天域生态关于控股股东所持股份解除质押的公告 | 2023-03-20 | Chinese | ||
| 38185043 | 天域生态关于控股子公司增资扩股的进展公告 | 2023-03-20 | Chinese | ||
| 38185027 | 天域生态关于向特定对象发行股票申请收到上海证券交易所审核意见通知的公告 | 2023-03-17 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
TIANYU BIO-TECHNOLOGY CO.,LTD. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/57798/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=57798 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=57798 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=57798 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 57798}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for TIANYU BIO-TECHNOLOGY CO.,LTD. (id: 57798)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.